ZhengWHuangXZhaoX, et al.Impact of stress hyperglycemia on the timing of complete revascularization in non-diabetes patients with ST elevation myocardial infarction and multivessel disease. Angiology. 2023;74:587-595.
2.
ŞimşekBÇınarTTanıkVO, et al.The association of acute--to--chronic glycemic ratio with no-reflow in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Kardiol Pol. 2021;79:170-178.
3.
MarenziGCosentinoNMilazzoV, et al.Prognostic value of the acute-to-chronic glycemic ratio at admission in acute myocardial infarction: a prospective study. Diabetes Care. 2018;41:847-853.
4.
GaoSLiuQDingXChenHZhaoXLiH. Predictive value of the acute-to-chronic glycemic ratio for in-hospitalmoutcomes in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention. Angiology. 2020;71:38-47.
5.
MartíDSalidoLMestreJL, et al.Impact of thrombus burden on procedural and mid-term outcomes after primary percutaneous coronary intervention. Coron Artery Dis. 2016;27:169-175.
6.
AngeråsOHaraldssonIRedforsB, et al.Impact of thrombus aspiration on mortality, stent thrombosis, and stroke in patients with ST-segment-elevation myocardial infarction: a report from the Swedish coronary angiography and angioplasty registry. J Am Heart Assoc. 2018;7:e007680.
7.
SigirciSYildizSSKeskinK, et al.The predictive value of stress hyperglycemia on thrombus burden in nondiabetic patients with ST-segment elevation myocardial infarction. Blood Coagul Fibrinolysis. 2019;30:270-276.
8.
NiccoliGBurzottaFGaliutoLCreaF. Myocardial no-reflow in humans. J Am Coll Cardiol. 2009;54:281-292.
9.
DaiWYeZLiLSuQ. Effect of preoperative loading dose ticagrelor and clopidogrel on no-reflow phenomenon during intervention in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a systematic review and meta-analysis. Drug Des Dev Ther. 2018;12:2039-2049.
